CondAlign's Bonding Technology Supports New Research in Disease Modeling!

CondAlign's bonding technology will contribute to an exciting research project funded by the Research Council of Norway: “Integrated Convergent Technology for Precision Human Tissue and Disease Modeling.” Led by IMB Professor Joel C. Glover, the project brings together partners from the University of Oslo, SINTEF, Oslo University Hospital, Biogen, the Norwegian Brain Council, and CondAlign.

The research focuses on combining micro- and nanotechnology innovations to build a platform for studying diseases in human cells, including ALS.

Fikk 15 millioner fra Forskningsrådet - Institutt for medisinske basalfag